galactose has been researched along with Liver Neoplasms in 186 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (33.87) | 18.7374 |
| 1990's | 20 (10.75) | 18.2507 |
| 2000's | 22 (11.83) | 29.6817 |
| 2010's | 57 (30.65) | 24.3611 |
| 2020's | 24 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Alés, E; Castillejos, MC; Cepeda-Franco, C; de la Cruz-Ojeda, P; Flores, JA; Gutiérrez-Valencia, A; Khiar, N; Mena-Barragán, T; Muntané, J; Navarro-Villarán, E; Negrete, M; Romero-Ben, E; Rosales-Barrios, C | 1 |
| Chen, YY; Han, HH; He, XP; Hu, XL; James, TD; Li, J; Pan, ZQ; Xie, DH; Xie, HN; Zang, Y; Zhu, GB | 1 |
| Assawapanumat, W; Dwivedi, A; Mazumder, A; Nasongkla, N; Saeeng, R; Sungkarat, W | 1 |
| Chakraborty, K; Dhara, S | 1 |
| Ma, X; Mai, Z; Song, Y; Wang, G; Wang, M; Xia, W; Ye, Y; Zhang, M; Zhou, B | 1 |
| Quan, J; Zhang, Q; Zhang, T; Zhu, L | 1 |
| Calignano, A; Chegaev, K; De Caro, C; Gazzano, E; Lazzarato, L; Magliocca, S; Marabello, D; Riganti, C; Rimoli, MG; Rolando, B; Russo, R; Sodano, F; Spyrakis, F | 1 |
| Cheng, X; Gao, Y; Hu, S; Jiang, S; Ke, W; Li, M; Song, Z; Sun, P; Wang, G; Wang, Y; Zhang, C; Zhang, W; Zhang, Y; Zheng, QC | 1 |
| Cai, C; Li, J; Rong, X; Shao, M; Yang, C; Yu, G; Zhang, Y | 1 |
| Chen, X; Hu, J; Hu, X; Qiu, Z; Yuan, M; Zheng, G | 1 |
| Cai, H; Quan, J; Shao, D; Shen, F; Wu, H; Zhang, Y; Zheng, Y | 1 |
| Kurmi, BD; Paliwal, R; Paliwal, SR; Tekchandani, P | 1 |
| Ding, J; He, L; Ma, L; Shen, B; Shen, W; Xie, X; Xu, D; Zhou, C; Zhou, Y | 1 |
| Bonazza, D; Cavallaro, G; Cemazar, M; Craparo, EF; Dapas, B; Drago, SE; Farra, R; Grassi, G; Grassi, M; Kamensek, U; Perrone, F; Pozzato, G; Scaggiante, B; Truong, N; Zanconati, F | 1 |
| Jia, Q; Li, MY; Liu, HP; Niu, LL; Wang, Q; Wu, YR | 1 |
| Chakraborty, N; Konkle, ME; Menze, MA; Skolik, RA; Solocinski, J | 1 |
| Li, X; Lian, B; Pan, R; Sun, J; Tian, G; Wei, H; Wu, J; Zhang, B | 1 |
| Deng, L; Hu, H; Hu, J; Hu, X; Zhang, J; Zheng, G | 1 |
| Bi, C; Chen, Q; Li, X; Shi, H; Xu, H; Zhang, X | 1 |
| Ding, R; Wang, J; Wang, M; Wang, Y; Zhang, Z; Zhong, C | 1 |
| Chattopadhyay, D; Debnath, MC; Dewanjee, S; Ganguly, S; Gaonkar, R; Sen, R | 1 |
| Dang, Y; Ruan, L; Tian, Y; Xu, Z; Zhang, W | 1 |
| Du, Z; Fu, J; Hu, J; Mao, Y; Yin, J; You, Q; Zhang, P | 1 |
| Chen, Y; Huang, M; Liu, C; Liu, M; Liu, Y; Qu, D; Wang, L | 1 |
| Dou, WT; Han, HH; He, XP; Jiang, Y; Tan, C; Wu, P; Zhang, M | 1 |
| Dong, H; Gao, M; Lv, L; Ma, X; Tian, L; Tian, Y; Wang, C; Xu, H; Zhang, C; Zhang, J | 1 |
| Aladinskaia, AV; Alieva, IB; Beloglazkina, EK; Deyneka, EV; Ivanenkov, YA; Kireev, II; Kotelianski, VE; Kovalev, SV; Majouga, AG; Maklakova, SY; Petrov, RA; Petrov, SA; Saltykova, IV; Sergeeva, OV; Sofronova, AA; Trofimenko, AV; Yamansarov, EY; Yamidanov, RS; Zatsepin, TS | 1 |
| Dou, K; Duan, J; Liu, Q; Lu, P; Shang, R; Wang, J; Wang, L; Xia, C; Yang, X; Yang, Z | 1 |
| Chen, Y; Chern, GJ; Chiang, CC; Ho, TL; Huang, KW; Huang, RL; Huang, SF; Hwang, PB; Lai, YT; Shiue, TY; Sung, YC; Tsai, CL; Wang, SK | 1 |
| Dong, H; Gao, M; Li, Q; Pang, Y; Tian, Y; Wang, J; Wu, G; Xu, H; Zhang, B; Zhang, C; Zhang, H | 1 |
| Archana, MG; Joseph, MM; Maya, S; Padinjarathil, H; Preethi, GU; Shiji, R; Sreelekha, TT; Syama, HP; Unnikrishnan, BS | 1 |
| Abdel-Hamid, AZ; Abdel-Megeed, RM; Hamed, AR; Kadry, MO; Matloub, AA | 1 |
| Cen, LQ; Gao, J; Gao, XG; Huang, JD; Jiang, SS; Liu, L; Liu, Q; Liu, Y; Yao, H; Zhang, Q; Zong, ZM | 1 |
| Guo, QY; Li, WJ; Liao, MM; Lin, N; Mao, X; Mi, GJ; Shen, Y; Wang, XY; Webster, TJ; You, C; Zhang, YQ | 1 |
| Cheng, M; Liu, B; Ma, D; Zhi, K; Zhu, W | 1 |
| Hu, L; Huang, S; Huang, Y; Wan, J; Wang, D; Xia, Z; Xu, W; Zheng, G | 1 |
| Ding, R; Li, Z; Wang, J; Wang, M; Zhao, Z; Zhu, X | 1 |
| Chen, L; Chen, Q; Liu, H; Qian, M; Wang, J; Xia, J; Xia, Y; Zhang, L | 1 |
| Bhargava, S; Kulhari, H; Kuncha, M; Pooja, D; Sistla, R; Tunki, L; Vadithe, LN | 1 |
| Abd-Rabou, AA; Bharali, DJ; Mousa, SA | 1 |
| Cheng, J; Liu, Y; Wang, H; Xu, M | 1 |
| Chen, Z; Huang, J; Lin, L; Wei, H; Xue, E; Yang, J; Zhang, X | 1 |
| Abolafio, G; Cerroni, B; Margheritelli, S; Oddo, L; Paradossi, G; Viganò, L; Villa, R; Zaffaroni, N | 1 |
| Chen, Y; Du, YZ; Huang, FF; Liu, P; Shi, D; Wang, Y; Yu, RS; Zhu, XL | 1 |
| Chang, TC; Chuang, YJ; Lai, CH; Lin, CC; Tzou, DL | 1 |
| Han, L; Tang, C; Yin, C | 1 |
| Shen, LJ; Wu, FL; Yeh, TH | 1 |
| Guo, Z; Liu, C; Song, M; Wu, X; Zhang, P; Zhang, X; Zhao, Z | 1 |
| Ebrahim Attia, AB; Ge, R; Hedrick, JL; Oh, P; Rao, N; Tan, JP; Yang, C; Yang, YY | 1 |
| Chen, GR; He, XP; James, TD; Li, J; Li, KB; Tian, H; Wang, H; Zang, Y | 1 |
| Goldman, R; Koomen, J; Sanda, M; Wu, J; Yuan, W | 1 |
| Gao, S; Kong, D; Li, C; Lou, S; Wang, C; Wang, W; Zhang, J; Zhang, M; Zhao, Q | 1 |
| Chen, GR; He, XP; James, TD; Li, J; Shi, DT; Tian, H; Zang, Y; Zhou, D | 1 |
| Kumar, P; Narain, R; Quan, S; Wang, Y; Zhou, A | 1 |
| Chen, H; Fan, Y; Ma, N; Qi, X; Rui, Y; Wu, Z | 1 |
| Anil Kumar, PR; James, NR; Nishna, N; Raj, DK; Sarika, PR | 1 |
| Tong, JL; Wan, Y; Wang, LX; Wu, JQ; Xu, HF; Zhang, QA; Zheng, Q; Zhu, CD | 1 |
| Ding, Y; Guo, W; Han, J; Pei, M; Tang, X; Wang, T | 1 |
| Chen, Y; Liu, M; Liu, Y; Qu, D; Sun, W; Zhou, J | 1 |
| Chen, Y; Ding, XF; Liu, CY; Liu, MJ; Liu, YP; Qu, D | 1 |
| Ding, Y; Han, J; Shi, Y; Sun, Y; Tian, B; Wang, L; Zhang, J | 1 |
| Bak-Fredslund, KP; Keiding, S; Munk, OL; Sørensen, M | 1 |
| Feng, C; Ji, W; Liu, G; Wang, F; Zhu, Z | 1 |
| Cho, CS; Cho, MH; Choi, YJ; Gankhuyag, N; Jang, Y; Kim, HJ; Kim, S; Lee, AY; Maharjan, S; Singh, B; Yang, MS | 1 |
| Etokidem, E; Lai, K; Tang, M | 1 |
| Cheng, X; Fu, S; Hu, L; Tang, R; Wang, J; Wang, X; Yan, G; Yang, G; Zhang, P | 1 |
| Fan, F; Sun, XF | 1 |
| Kitano, H; Matsunaga, T; Mizukami, K; Takakura, H | 1 |
| Chakrabarti, RN; Chatterjee, M; Das, N; Das, S; Mandal, AK; Mitra, M | 1 |
| DERSE, PH; ELVEHJEM, CA; HART, EB | 1 |
| Gupta, GK; Jain, V; Mishra, PR; Nath, B; Pant, AB; Shah, PP; Siddiqui, MA | 1 |
| Jia, FG; Meng, Z; Xu, YK; Zhang, XD | 1 |
| Bei, YY; Hu, W; Hu, ZH; Wang, Q; Wang, WJ; Xu, JY; Zhang, L; Zhang, Q; Zhang, XN | 1 |
| Blomme, B; Callewaert, N; Colle, I; Van Steenkiste, C; Van Vlierberghe, H; Vanhuysse, J | 1 |
| Hai, L; Lu, J; Sun, X; Wu, Y; Zhang, ZR; Zhu, D | 1 |
| Chen, D; Deng, YH; Liu, Y; Wang, S; Xu, H; Xu, J; Zhang, Y | 1 |
| Ma, GH; Qu, JB; Su, ZG; Wei, W; Yue, H; Yue, ZG | 1 |
| Qian, J; Suo, A; Yao, Y; Zhang, W | 1 |
| Chen, H; Cheng, M; Cheng, Z; He, B; Hong, X; Li, Q; Wan, T; Wu, J; Xu, H; Ye, T; Zha, B; Zhou, R | 1 |
| Duan, C; Gao, J; Jia, L; Liu, G; Liu, Y; Tian, X; Wang, F; Zhang, D; Zhang, Q; Zheng, D | 1 |
| Ding, F; Jiang, G; Qiu, T; Wang, Y | 1 |
| Hassanzadeh, F; Khadem, M; Sadeghi, H; Varshosaz, J | 1 |
| Chandra, R; Garg, M; Katyal, A; Madan, J; Pandey, RS; Sardana, S | 1 |
| Ariatti, M; Dorasamy, S; Narainpersad, N; Singh, M | 1 |
| Fumoto, S; Hashida, M; Hattori, Y; Kawakami, S; Morimoto, K; Nakano, T; Nishikawa, M; Yamashita, F | 1 |
| Hara, K; Isozaki, T; Kiba, T; Kubota, T; Morimoto, M; Morizane, T; Numata, K; Sakaguchi, T; Sekihara, H; Shimada, H; Tanaka, K | 1 |
| Dwi Bahagia, A; Hamakawa, M; Kobayashi, K; Kubota, M; Naito, K; Nishimura, Y; Ono, H; Saheki, T; Sakamoto, A; Sakura, N; Tajima, G; Yoshii, C | 1 |
| Cho, CS; Choi, YJ; Kim, TH; Nah, JW; Park, IK | 1 |
| Filippi, C; Hayes, PC; Keatch, SA; Nelson, LJ; Plevris, JN; Rangar, D | 1 |
| Jiang, JW; Zhang, Y | 1 |
| Hashida, M; Iwai, M; Kawakami, S; Terada, T; Yamashita, F | 1 |
| Fei, R; Qi, XR; Shi, J; Wei, L; Yang, L | 1 |
| Isozaki, T; Kunisaki, R; Morimoto, M; Morizane, T; Numata, K; Sugimori, K; Tanaka, K | 1 |
| Kakimoto, S; Kano, H; Nagasaki, T; Nakatani, M; Satoh, T; Shinkai, S | 1 |
| Arkosy, M; Fazakas, J; Füle, B; Hidvégi, M; Mándli, T; Németh, E; Ther, G; Tóth, S | 1 |
| de Verdier, CH; Hjelm, M; Tengström, B; Werner, I | 1 |
| Schwartz, AL; Simmons, CF | 1 |
| Bernaert, D; Deschuyteneer, M; May, C; Prieels, JP; Wanson, JC | 1 |
| Ishida, N; Nakagomi, A; Nakagomi, O; Shiraishi, H; Yamada, E | 1 |
| Ashwell, G; Steer, CJ | 1 |
| Baker, AL; Kotake, AN; Schoeller, DA | 1 |
| Kichler, A; Schuber, F | 1 |
| Imaoka, T; Kitamra, T; Kitamura, S; Ooura, Y; Tanaka, S; Yamamoto, K; Yoshioka, F | 1 |
| Hirohata, T; Jinnai, H; Nakamura, K; Okuno, K; Shigeoka, H; Yasutomi, M | 1 |
| Davit-Spraul, A; Lemonnier, A; Ng, KH; Pourci, ML; Soni, T | 1 |
| Chen, J; Daichendt, KA; Stickles, RJ | 1 |
| Davit-Spraul, A; Lemonnier, A; Pourci, ML; Soni, T | 1 |
| Hanafusa, T; Higashi, T; Kajitani, M; Kurokawa, T; Ogawa, H; Ohshima, K; Tsuboi, H; Umeda, M; Yumoto, E; Yumoto, Y | 1 |
| Bagai, S; Sarkar, DP | 1 |
| Endo, M; Okahata, Y; Sato, T | 1 |
| Bellon, S; Bianco, S; Bolognesi, M; Chiesura-Corona, M; Enzo, E; Feltrin, G; Gatta, A; Merkel, C; Miotto, D; Savastano, S | 1 |
| Hashida, M; Kawakami, S; Nishikawa, M; Takakura, Y; Yamashita, F | 1 |
| Basset, C; Devauchelle, V; Dueymes, M; Durand, V; Jamin, C; Pennec, YL; Youinou, P | 1 |
| Büchler, MW; Dufour, JF; Hüsler, J; Krähenbühl, L; Redaelli, CA; Reichen, J; Schilling, M; Wagner, M | 1 |
| Bridge, JH; Jensen, KD; Kopecek, J; Kopecková, P | 1 |
| Ikehara, Y; Kato, K; Oda, K | 1 |
| Engvall, E; Goldstein, IJ; Hammarström, S; Johansson, BG; Sundblad, G; Svensson, S | 1 |
| Dorfman, A; Galligani, L; Hopwood, J; Schwartz, NB | 1 |
| Cifonelli, JA; Joung, JI; Levin, B; Rochman, H | 1 |
| Bergelson, LD; Dyatlovitskaya, EV; Gorkova, NP; Novikov, AM | 1 |
| Bustamante, E; Pedersen, PL | 1 |
| Bourrillon, R; Dodeur, M | 1 |
| Bircher, J; Colombo, JP | 1 |
| Balcells, A; Carbonell, J; Font, J; Prellezo, P; Vivancos, J | 1 |
| Nakamura, S; Sato, T; Takezawa, Y; Yoshida, G | 1 |
| Ishizuka, I; Kosaki, G; Yamakawa, T; Yamamoto, T | 1 |
| Geilen, CC; Grunow, D; Heidrich, C; Kannicht, C; Nuck, R; Orthen, B; Paul, C; Reutter, W | 1 |
| Hu, OY; Tang, HS | 1 |
| Su, S; Tan, R; Zhou, C; Zhou, Z | 1 |
| Hagmar, B; Ryd, W; Skomedal, H | 1 |
| Busemann-Sokole, E; Chamuleau, RA; Jansen, PL; Schipper, HG; van der Heyde, MN; van Leeuwen, DJ | 1 |
| Adams, TJ; Cowart, RE; Lashmet, J; McIntosh, ME | 1 |
| Chytrý, V; Duncan, R; Hume, IC; Kopecek, J; Kopecková, P; O'Hare, KB; Scarlett, L | 1 |
| Bland, KI; Copeland, EM; Kimura, AK; Yeatman, TJ | 1 |
| Birardi, A; Buzzelli, G; Chiarantini, E; Meacci, E; Smorlesi, C | 1 |
| Birardi, A; Buzzelli, G; Chiarantini, E; Gentilini, P; Meacci, E; Smorlesi, C | 1 |
| Begley, JA; Green-Colligan, PD; Hall, CA | 1 |
| Marchesini, G; Marra, A; Marrano, D; Melli, A; Pisi, E; Viti, G; Zoli, M | 1 |
| Beuth, J; Ko, HL; Oette, K; Pulverer, G; Roszkowski, K; Uhlenbruck, G | 1 |
| Budillon, G; Carrella, M; Colombi, A; Coltorti, M; Di Simone, A; Lucchelli, PE; Oriani, GA | 1 |
| Aikawa, T; Kera, K; Nakamura, S; Nakamura, T; Onodera, A | 1 |
| Smetana, HF | 1 |
| Kaneko, I; Sato, H; Ukita, T | 1 |
| Phillips, JL | 1 |
| Keppler, DO; Smith, DF | 1 |
| Funakoshi, I; Nakada, H; Yamashina, I | 2 |
| Decker, K; Keppler, D | 1 |
| Kuntz, E | 1 |
| Aikawa, T; Iida, H; Nakamura, S; Nakamura, T; Onodera, A; Suzuki, O | 1 |
| Bouchier, IA; Clamp, JR | 1 |
| Tengström, B | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Achaintre, D; Agnoli, C; Agudo, A; Ardanaz, E; Arriola, L; Bachlechner, U; Bamia, C; Boeing, H; Bueno-de-Mesquita, B; Carayol, M; Ferrari, P; Hansen, L; Huerta, JM; Jenab, M; Kaaks, R; Key, TJ; Khaw, KT; Kühn, T; Leitzmann, MF; Melander, O; Nilsson, J; Overvad, K; Palli, D; Panico, S; Peeters, PH; Quirós, JR; Rinaldi, S; Sánchez-Cantalejo, E; Scalbert, A; Schmidt, JA; Stepien, M; Tjønneland, A; Travis, RC; Trichopoulou, A; Tumino, R; Vineis, P; Wareham, N; Zamora-Ros, R | 1 |
| Dauer, A; Hensel, A; Knasmüller, S; Lhoste, E; Mersch-Sundermann, V | 1 |
| FEO, F; GABRIEL, L; GRAVELA, E; TERRANOVA, T | 1 |
| COHEN, J; SCHWARTZ, MA; WEST, M; ZIMMERMAN, HJ | 1 |
| CHYREK-BOROWSKA, S; DEPTULSKI, T | 1 |
| Alam, A; Singh, V; Singha, LI | 1 |
| Hajjar, KA; Reynolds, CM | 1 |
| Chen, JF; Guo, JH; Malbon, CC; Moxham, CM; Wang, HY | 1 |
| Juárez, O; Moreno-Sánchez, R; Rodríguez-Enríquez, S; Rodríguez-Zavala, JS | 1 |
| Imamura, A; Kaibori, M; Kamiyama, Y; Kawaguchi, Y; Kitade, H; Kwon, AH; Matsui, Y; Satoi, S; Takai, S; Uhara, J; Yamada, H | 1 |
| Capetillo, SC; Davis, EM; Gilliam, EB; Robinson, JM; Smith, DF; Walborg, EF | 1 |
| Funakoshi, I; Mutoh, S; Yamashina, I | 1 |
| Reutter, W; Vischer, P | 1 |
| Graff, JC; Marz, R; Plagemann, PG; Wohlhueter, RM | 1 |
| Masuda, H; Shichijo, S; Takeuchi, M | 1 |
| Belogortseva, NI; Kurika, AV; Nabiullin, AA; Ovodov, IuS; Pavlenko, AF | 1 |
| Nigam, VN | 1 |
| Cristofalo, VJ; Lo, C; Morris, HP; Weinhouse, S | 1 |
| Morris, HP; Shatton, JB; Weinhouse, S | 1 |
| Nagase, S; Sato, H | 1 |
| Funakoshi, I; Shimizu, S | 1 |
| Mester, L; Soria, J; Szabados, L | 1 |
| Kikuchi, H; Kobayashi, Y; Tsuiki, S | 1 |
| Mizel, SB; Wilson, L | 1 |
| Ebstensen, RD; Plagemann, PG | 1 |
| Funakoshi, I; Yamashina, I | 1 |
| Hayashi, Y | 1 |
| Anno, K; Kuroda, J; Nagase, S; Saito, S; Seno, N | 1 |
| Gilliam, EB; Neri, G; Smith, DF; Walborg, EF | 1 |
| Burk, D; Hunter, J; Woods, M | 1 |
| Boctor, A; Grossman, A; Mendelson, D | 1 |
| Plagemann, GW; Renner, ED | 1 |
8 review(s) available for galactose and Liver Neoplasms
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
[Evaluation of liver function before living donor liver transplantation and liver resection].
Topics: Aminopyrine; Biliary Tract; Breath Tests; Carcinoma, Hepatocellular; Cholangiocarcinoma; Galactose; Hepatectomy; Humans; Indocyanine Green; Liver; Liver Circulation; Liver Failure, Acute; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Living Donors; Oxidative Stress; Portal System; Predictive Value of Tests; Radionuclide Imaging; Serum Albumin; Tomography, X-Ray Computed | 2008 |
Clinical utility of breath tests for the assessment of hepatic function.
Topics: Aminopyrine; Breath Tests; Caffeine; Chemical and Drug Induced Liver Injury; Chronic Disease; Cytochrome P-450 Enzyme System; Galactose; Hepatitis; Hepatitis, Alcoholic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Function Tests; Liver Neoplasms; Pharmacology; Phenacetin; Prognosis | 1983 |
[Liver tests and tests of liver function (author's transl)].
Topics: Aminopyrine; Cholestasis; Clinical Enzyme Tests; Galactose; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Neoplasm Metastasis; Sulfobromophthalein | 1978 |
Cirrhosis of the liver: principles of classification, histogenesis, and pathogenesis.
Topics: Adult; Aged; Animals; Female; Galactose; Haplorhini; Hemochromatosis; Humans; Inclusion Bodies; Infant; Infant, Newborn; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Neoplasms; Macaca; Male; Metabolism, Inborn Errors; Nutrition Disorders; Portal System | 1972 |
Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.
Topics: Animals; Blood Coagulation Factors; Carbohydrates; Carcinoma, Hepatocellular; Cell Survival; Chemical and Drug Induced Liver Injury; Deoxy Sugars; Disease Models, Animal; Galactosamine; Galactose; Glucosamine; Hyperbilirubinemia; Liver Neoplasms; Macromolecular Substances; Protein Biosynthesis; Pyrimidine Nucleotides; RNA; Time Factors; Uracil Nucleotides; Uridine; Uridine Diphosphate Sugars | 1974 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Inhibition of carrier-mediated and non-mediated permeation processes by cytochalasin B.
Topics: Animals; Biological Transport; Biological Transport, Active; Blood Glucose; Carcinoma, Hepatocellular; Cytochalasin B; Cytochalasins; Deoxyglucose; Erythrocytes; Hexoses; Humans; Kinetics; Liver Neoplasms; Methylglucosides; Neoplasms, Experimental; Rats; Thermodynamics | 1978 |
5 trial(s) available for galactose and Liver Neoplasms
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.
Topics: Antibodies, Neoplasm; Carcinoma, Hepatocellular; Female; Galactose; Glycosylation; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Mass Spectrometry; Middle Aged | 2015 |
Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma.
Topics: Adult; Aged; Blood Flow Velocity; Carcinoma, Hepatocellular; Chronic Disease; Contrast Media; Female; Galactose; Hepatitis; Humans; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polysaccharides; Ultrasonography, Doppler, Color | 1995 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study.
Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Follow-Up Studies; Food, Organic; Hexoses; Humans; Immunologic Factors; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Polysaccharides; Prognosis; Prospective Studies | 2002 |
175 other study(ies) available for galactose and Liver Neoplasms
| Article | Year |
|---|---|
PDA-Based Glyconanomicelles for Hepatocellular Carcinoma Cells Active Targeting Via Mannose and Asialoglycoprotein Receptors.
Topics: Antineoplastic Agents; Apoptosis; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Proliferation; Endosomes; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Mannose; Mannose Receptor; Micelles; Nanoparticles; Polyacetylene Polymer; Sorafenib | 2021 |
Targeted delivery of maytansine to liver cancer cells
Topics: Cell Line; Cell Line, Tumor; Galactose; Humans; Liver Neoplasms; Maytansine; Serum Albumin, Human | 2022 |
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Galactose; Humans; Liver Neoplasms; Micelles | 2022 |
Apoptotic effect of sulfated galactofucan from marine macroalga Turbinaria ornata on hepatocellular and ductal carcinoma cells.
Topics: Apoptosis; Camptothecin; Carcinoma, Ductal; Carcinoma, Hepatocellular; Fucose; Galactose; Hep G2 Cells; Humans; Isothiocyanates; Liver Neoplasms; Phaeophyceae; Polysaccharides; Seaweed; Sulfates; Tumor Suppressor Protein p53 | 2022 |
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery.
Topics: Animals; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drugs, Chinese Herbal; Galactose; Glycosides; Humans; Liver Neoplasms; Mice; Silicon Dioxide; Ubiquitin-Protein Ligases | 2022 |
Galactose-functionalized injectable thermosensitive microgels for target specific uptake in hepatoma cells.
Topics: Carcinoma, Hepatocellular; Doxorubicin; Galactose; Gels; Humans; Liver Neoplasms; Microgels | 2023 |
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Galactose; Humans; Hyperalgesia; Liver Neoplasms; Male; Mice; Pain, Postoperative; Prodrugs; Tumor Cells, Cultured | 2019 |
Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma.
Topics: Animals; Biocompatible Materials; Carcinoma, Hepatocellular; Chitosan; Galactose; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Nanoparticles; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |
Collaborative assembly of doxorubicin and galactosyl diblock glycopolymers for targeted drug delivery of hepatocellular carcinoma.
Topics: Animals; Biocompatible Materials; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Doxorubicin; Drug Carriers; Drug Liberation; Embryo, Nonmammalian; Galactose; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Nanoparticles; Polymers; Proto-Oncogene Proteins p21(ras); Zebrafish; Zebrafish Proteins | 2020 |
Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Survival; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Galactose; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Mice; Particle Size; Pentacyclic Triterpenes; Phosphatidylethanolamines; Polyethylene Glycols; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Solubility; Transfection; Treatment Outcome | 2020 |
Galactose-functionalized GlycoAuNR as a photothermal conversion complex: Its binding to lectin RCA
Topics: Agglutinins; Carcinoma, Hepatocellular; Flow Cytometry; Galactose; Gene Expression Regulation, Neoplastic; Gold; Hep G2 Cells; Humans; In Vitro Techniques; Lasers; Liver Neoplasms; Metal Nanoparticles; Microscopy, Confocal; Nanotubes; Photochemistry; Plant Lectins; Polymers; Ricinus; Spectroscopy, Near-Infrared | 2020 |
Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Drug Development; Female; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Male; Random Allocation; Rats; Tissue Distribution; Vitamin E | 2020 |
Characterization of a polysaccharide from Eupolyphaga sinensis walker and its effective antitumor activity via lymphocyte activation.
Topics: Animals; Antineoplastic Agents; Arabinose; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, Gel; Chromatography, Ion Exchange; Cockroaches; Female; Fucose; Galactose; Glucose; Killer Cells, Natural; Liver Neoplasms; Lymphocyte Activation; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Polysaccharides; Rhamnose; Xylose | 2020 |
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer.
Topics: Animals; Carcinoma, Hepatocellular; Galactose; Liver Neoplasms; Mice; Polymers; RNA, Small Interfering | 2021 |
Structural characterization of a novel polysaccharide from Pleurotus citrinopileatus and its antitumor activity on H22 tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arabinose; Cell Cycle; Cell Division; China; Galactose; Glucuronic Acid; Glycosides; Liver Neoplasms; Male; Mannose; Mice; Molecular Weight; Monosaccharides; Pleurotus; Polysaccharides; Xylose | 2021 |
Global changes to HepG2 cell metabolism in response to galactose treatment.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Energy Metabolism; Galactose; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Metabolome; Mitochondria, Liver; Oxidation-Reduction; Phenotype; Time Factors; Transcriptome | 2021 |
Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Doxorubicin; Drug Compounding; Galactose; Human Umbilical Vein Endothelial Cells; Humans; Liposomes; Liver Neoplasms; Mice; Particle Size; Stilbenes | 2021 |
Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Galactose; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Liver Neoplasms; Male; Mice; Random Allocation; Rats; Rats, Sprague-Dawley | 2021 |
Structure elucidation of arabinogalactoglucan isolated from Sedum sarmentosum Bunge and its inhibition on hepatocellular carcinoma cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; Arabinose; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Galactose; Glucans; Humans; Liver Neoplasms; Molecular Weight; Plant Extracts; Sedum | 2021 |
Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Curcumin; Galactose; Humans; Liposomes; Liver Neoplasms; Lysosomes | 2021 |
Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma.
Topics: Animals; Apigenin; Carcinoma, Hepatocellular; Drug Carriers; Galactose; Liver Neoplasms; Nanoparticles; Particle Size; Rats | 2021 |
Nitric Oxide Prodrug Delivery and Release Monitoring Based on a Galactose-Modified Multifunctional Nanoprobe.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Galactose; Liver Neoplasms; Mice; Mice, Nude; Nitric Oxide; Prodrugs | 2021 |
TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Drug Therapy; Galactose; Humans; Indoles; Infrared Rays; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nitric Oxide Donors; Nitroso Compounds; Photothermal Therapy; Polymers; Rats, Sprague-Dawley; Vitamin E; Xenograft Model Antitumor Assays | 2021 |
Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Coix; Drug Delivery Systems; Emulsions; Esters; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Particle Size; Seeds; Xenograft Model Antitumor Assays | 2017 |
Conjugated polyelectrolytes with galactose-containing side chains for targeted hepatoma cell imaging.
Topics: Alkynes; Carcinoma, Hepatocellular; Cell Line, Tumor; Ethers; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Structure; Optical Imaging; Polyelectrolytes | 2017 |
Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy.
Topics: Animals; Bufanolides; Galactose; Humans; Lactic Acid; Liver Neoplasms; Mice; Nanoparticles; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates.
Topics: Antineoplastic Agents, Phytogenic; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Structure; Paclitaxel; Small Molecule Libraries; Structure-Activity Relationship | 2018 |
Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dextrans; Galactose; Gene Silencing; Gene Transfer Techniques; Half-Life; Humans; Liver Neoplasms; Magnetite Nanoparticles; Mice, Inbred C57BL; Mice, Nude; Polyethyleneimine; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Tissue Distribution | 2018 |
Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
Topics: Animals; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Drug Delivery Systems; Galactose; Liver Neoplasms; Mice; Nanoparticles; Neoplasm Proteins; RNA, Small Interfering; Tumor Microenvironment | 2018 |
N-acetylaminogalactosyl-decorated biodegradable PLGA-TPGS copolymer nanoparticles containing emodin for the active targeting therapy of liver cancer.
Topics: Apoptosis; Biological Transport; Drug Carriers; Emodin; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Targeted Therapy; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2018 |
Galactomannan endowed biogenic silver nanoparticles exposed enhanced cancer cytotoxicity with excellent biocompatibility.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Erythrocytes; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Lythraceae; Mannans; Materials Testing; Metal Nanoparticles; Silver | 2018 |
Regulation of apoptotic and inflammatory signaling pathways in hepatocellular carcinoma via Caesalpinia gilliesii galactomannan.
Topics: Animals; Apoptosis; Caesalpinia; Carcinoma, Hepatocellular; Cell Proliferation; Galactose; Humans; Inflammation; Liver; Liver Neoplasms; Male; Mannans; Plant Extracts; Rats; Rats, Wistar; Tumor Cells, Cultured | 2019 |
A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma.
Topics: Animals; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cross-Linking Reagents; DNA; Drug Carriers; Female; Galactose; Genes, Reporter; Hepatocytes; Humans; Immunotherapy; Inositol; Interleukin-15; Liver Neoplasms; Mice, Inbred BALB C; Molecular Weight; Nanoparticles; Plasmids; Polyethylene Glycols; Polyethyleneimine | 2018 |
Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Diterpenes; Epoxy Compounds; Galactose; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Nanoparticles; Phenanthrenes; Reproduction; Signal Transduction; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Biotin; Cell Line; Cell Movement; Cell Proliferation; Chitosan; Drug Carriers; Fluorouracil; Galactose; Humans; Liver; Liver Neoplasms; Magnetic Resonance Spectroscopy; Mice; Nanoparticles; Optical Imaging; Particle Size; Spectroscopy, Fourier Transform Infrared | 2018 |
Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Topics: Antineoplastic Agents; Apoptosis; Binding, Competitive; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Curcumin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Endocytosis; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles; Particle Size; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Transcription Factor RelA | 2018 |
Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell-Targeting Effect.
Topics: Antineoplastic Agents; Asialoglycoprotein Receptor; Biotin; Camptothecin; Carcinoma, Hepatocellular; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Galactose; Hep G2 Cells; Hepatocytes; Humans; Lipids; Liposomes; Liver Neoplasms; Particle Size | 2019 |
Poly(lactobionamidoethyl methacrylate)-based amphiphiles with ultrasound-labile components in manufacture of drug delivery nanoparticulates for augmented cytotoxic efficacy to hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Survival; Doxorubicin; Drug Carriers; Drug Liberation; Galactose; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Kinetics; Liver Neoplasms; Nanoparticles; Polymerization; Polymethacrylic Acids; Ultrasonic Waves | 2019 |
Modulating the site-specific oral delivery of sorafenib using sugar-grafted nanoparticles for hepatocellular carcinoma treatment.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Drug Liberation; Galactose; Hep G2 Cells; Humans; Lipids; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Nanoparticles; Polyethylene Glycols; Sorafenib; Tissue Distribution | 2019 |
Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis.
Topics: Angiogenesis Inhibitors; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanoparticles; Neovascularization, Pathologic; Ribavirin | 2020 |
Azido-galactose outperforms azido-mannose for metabolic labeling and targeting of hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Azides; Carbon Radioisotopes; Carcinoma, Hepatocellular; Doxorubicin; Female; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Mannose; Metabolic Engineering; Mice, Nude; Staining and Labeling | 2019 |
Ultrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Biomarkers; Carcinoma, Hepatocellular; Docetaxel; Drug Carriers; Female; Galactose; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Ki-67 Antigen; Lactic Acid; Liver Neoplasms; Male; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Real-Time Polymerase Chain Reaction; Repressor Proteins; Sound; Survivin; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Chitosan; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Microbubbles; Molecular Structure; Polymers; Structure-Activity Relationship | 2013 |
Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate.
Topics: Adenosine Triphosphate; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Drug Carriers; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles | 2013 |
Stepwise orthogonal click chemistry toward fabrication of paclitaxel/galactose functionalized fluorescent nanoparticles for HepG2 cell targeting and delivery.
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Click Chemistry; Drug Delivery Systems; Fluorescent Dyes; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles; Paclitaxel | 2013 |
Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Female; Galactose; Genetic Therapy; Humans; Inhibitor of Apoptosis Proteins; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; RNA Interference; RNA, Small Interfering; Survivin; Vascular Endothelial Growth Factor A | 2014 |
Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells.
Topics: Albumins; Apoptosis; Cell Line, Tumor; Cytochromes c; Galactose; Humans; Liver Neoplasms; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.
Topics: Animals; Asialoglycoprotein Receptor; Cell Line, Tumor; Chemistry, Pharmaceutical; Female; Galactose; Hydrazines; Liver; Liver Neoplasms; Mice; Mice, Inbred C57BL; Nicotinic Acids; Organotechnetium Compounds; Polystyrenes; Radioactive Tracers; Radiochemistry; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2014 |
Insights into EPR effect versus lectin-mediated targeted delivery: biodegradable polycarbonate micellar nanoparticles with and without galactose surface decoration.
Topics: Animals; Biodegradable Plastics; Carcinoma, Hepatocellular; Cell Membrane Permeability; Coated Materials, Biocompatible; Drug Carriers; Drug Delivery Systems; Galactose; Galectin 3; Humans; Lectins; Liver Neoplasms; Micelles; Nanoparticles; Polycarboxylate Cement; Rats; Rats, Inbred BUF; Surface Properties; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Hepatoma-selective imaging of heavy metal ions using a 'clicked' galactosylrhodamine probe.
Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Click Chemistry; Fluorescent Dyes; Galactose; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; Mercury; Rhodamines; RNA, Messenger | 2014 |
Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery.
Topics: Antineoplastic Agents; Asialoglycoproteins; Bacillus subtilis; Biocompatible Materials; Body Temperature; Carcinoma, Hepatocellular; Cross-Linking Reagents; Drug Carriers; Drug Delivery Systems; Esters; Flow Cytometry; Galactose; Gels; Glutathione; Humans; Hydrogen-Ion Concentration; Liver; Liver Neoplasms; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Oxidation-Reduction; Temperature; X-Ray Diffraction | 2015 |
Selective fluorogenic imaging of hepatocellular H2S by a galactosyl azidonaphthalimide probe.
Topics: Azides; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorescent Dyes; Galactose; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Hydrogen Sulfide; Liver Neoplasms; Molecular Imaging; Molecular Structure; Naphthalimides | 2015 |
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanogels; Nitroimidazoles; Polyethylene Glycols; Polyethyleneimine; Radiation-Sensitizing Agents; Temperature; Theranostic Nanomedicine | 2015 |
Galactosylated chitosan-grafted multiwall carbon nanotubes for pH-dependent sustained release and hepatic tumor-targeted delivery of doxorubicin in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Chitosan; Doxorubicin; Galactose; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Male; Mice; Mice, Nude; Nanotubes, Carbon | 2015 |
Galactosylated pullulan-curcumin conjugate micelles for site specific anticancer activity to hepatocarcinoma cells.
Topics: Antineoplastic Agents; Curcumin; Drug Stability; Galactose; Glucans; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Electron, Scanning | 2015 |
Synthesis of novel galactose functionalized gold nanoparticles and its radiosensitizing mechanism.
Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Drug Delivery Systems; Galactose; Gold; Hep G2 Cells; Humans; Liver Neoplasms; Metal Nanoparticles; Oxidative Stress; Particle Size; Polyethylene Glycols | 2015 |
Biodegradable Self-Assembled Nanoparticles of Galactose-Containing Amphiphilic Triblock Copolymers for Targeted Delivery of Paclitaxel to HepG2 Cells.
Topics: Drug Delivery Systems; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles; Paclitaxel; Polymers; Surface-Active Agents | 2016 |
Bitargeted microemulsions based on coix seed ingredients for enhanced hepatic tumor delivery and synergistic therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Coix; Emulsions; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Inbred ICR; Mice, Nude; Plant Oils; Polysaccharides; Seeds; Tumor Burden | 2016 |
Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Coix; Drug Carriers; Drug Delivery Systems; Emulsions; Esters; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Particle Size; Plant Extracts; Tissue Distribution | 2016 |
Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
Topics: A549 Cells; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Liberation; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanoparticles; Polyethylene Glycols; Polymers | 2017 |
2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
Topics: Aged; Carcinoma, Hepatocellular; Fucose; Galactose; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2016 |
Galactose-decorated light-responsive hydrogelator precursors for selectively killing cancer cells.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Galactose; Humans; Hydrogels; Light; Liver Neoplasms; Tumor Cells, Cultured | 2016 |
Combination therapy with doxorubicin-loaded galactosylated poly(ethyleneglycol)-lithocholic acid to suppress the tumor growth in an orthotopic mouse model of liver cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Galactose; Lithocholic Acid; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanocapsules; Polyethylene Glycols; Treatment Outcome | 2017 |
The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Galactokinase; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; RNA, Small Interfering; UTP-Hexose-1-Phosphate Uridylyltransferase | 2016 |
Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; Disaccharides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Dynamic Light Scattering; Galactose; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Liver Neoplasms; Mice; Micelles; Particle Size; Polymers; Proton Magnetic Resonance Spectroscopy; Tissue Distribution; Treatment Outcome | 2017 |
[Synthesis and anticancer activity of norcantharidin-galactose derivatives].
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Female; Galactose; Humans; Liver Neoplasms; Male; Mice; Neoplasm Transplantation; Prodrugs | 2008 |
Binding of Ricinus communis agglutinin to a galactose-carrying polymer brush on a colloidal gold monolayer.
Topics: Adsorption; Carcinoma, Hepatocellular; Galactose; Gold Colloid; Lectins; Liver Neoplasms; Methacrylates; Plant Lectins; Polymers; Tumor Cells, Cultured | 2008 |
Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model.
Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Catalase; Diethylnitrosamine; Drug Carriers; Drug Compounding; Galactose; Glutathione Peroxidase; Intercalating Agents; Lipid Peroxidation; Liposomes; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Microscopy, Electron; Microsomes, Liver; Organ Size; Quercetin; Rats | 2008 |
Galactose excretion in young and hepatoma rats fed skim milk diets.
Topics: Animals; Blood; Body Fluids; Carcinoma, Hepatocellular; Dairy Products; Diet; Galactose; Liver Neoplasms; Milk; Penicillins; Rats | 1947 |
Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines.
Topics: Antineoplastic Agents, Phytogenic; Asialoglycoprotein Receptor; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Chylomicrons; Drug Delivery Systems; Emulsions; Female; Galactosamine; Galactose; Humans; Liver Neoplasms; Paclitaxel; Palmitic Acid; Particle Size | 2009 |
[Synthesis of Gal-BSA-SPIO and magnetic resonance imaging of ASG receptors in rabbits bearing liver VX2 tumor and human liver].
Topics: Animals; Asialoglycoprotein Receptor; Contrast Media; Dextrans; Female; Ferric Compounds; Ferrosoferric Oxide; Galactose; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Rabbits; Serum Albumin, Bovine | 2009 |
Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Drug Carriers; Galactose; Liver Neoplasms; Mice; Nanoparticles | 2010 |
Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Bilirubin; Carbohydrate Sequence; Carbon Tetrachloride Poisoning; Carcinoma, Hepatocellular; Common Bile Duct; Female; Fucose; Galactose; Glycosylation; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged; Polysaccharides | 2010 |
Novel synthetic LPDs consisting of different cholesterol derivatives for gene transfer into hepatocytes.
Topics: Animals; Asialoglycoprotein Receptor; Binding Sites; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA; Galactose; Gene Transfer Techniques; Genetic Vectors; Hep G2 Cells; Hepatocytes; Humans; Lipids; Liposomes; Liver Neoplasms; Mice; Protamines | 2010 |
Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Doxorubicin; Drug Compounding; Galactose; Lipids; Liposomes; Liver; Liver Neoplasms; Metabolic Clearance Rate; Mice; Polyethylene Glycols; Tissue Distribution | 2010 |
Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatography, High Pressure Liquid; Flow Cytometry; Galactose; Humans; In Vitro Techniques; Liver Neoplasms; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Nanostructures; Solubility | 2010 |
Galactosylated poly(ethylene glycol)-b-poly (l-lactide-co-β-malic acid) block copolymer micelles for targeted drug delivery: preparation and in vitro characterization.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Cycle; Cell Survival; Doxorubicin; Drug Delivery Systems; Galactose; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Malates; Micelles; Microscopy, Confocal; Polyesters; Polyethylene Glycols | 2010 |
Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.
Topics: Animals; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Female; Galactose; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Hepatocytes; Interleukins; Liver Neoplasms; Materials Testing; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles; Random Allocation; Recombinant Fusion Proteins; Spectroscopy, Fourier Transform Infrared; Tissue Distribution; Transfection | 2011 |
Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
Topics: Acrylamides; Carcinoma, Hepatocellular; Chitosan; Diterpenes, Kaurane; Drug Carriers; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanogels; Polyethylene Glycols; Polyethyleneimine | 2011 |
Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Survival; Drug Compounding; Drug Delivery Systems; Emulsifying Agents; Endocytosis; Galactose; Hep G2 Cells; Hepatocytes; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactose; Liver Neoplasms; Nanoparticles; Paclitaxel; Particle Size; Polystyrenes; Polyvinyl Alcohol; Solubility; Surface Properties | 2012 |
Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Topics: Acetone; Amines; Antineoplastic Agents; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Delayed-Action Preparations; Disaccharides; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Fluorouracil; Galactose; Glycerides; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Nanoparticles; Oleic Acid; Particle Size; Polysorbates; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tetrazolium Salts; Thiazoles; Toxicity Tests | 2012 |
Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Proliferation; Doxorubicin; Drug Delivery Systems; Galactose; Gelatin; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Liver Neoplasms; Male; Mice; Nanospheres; Particle Size; Tissue Distribution | 2012 |
Novel targeted liposomes deliver sirna to hepatocellular carcinoma cells in vitro.
Topics: Carcinoma, Hepatocellular; Drug Delivery Systems; Galactose; HEK293 Cells; Hep G2 Cells; Hepatocytes; Humans; Liposomes; Liver Neoplasms; RNA, Small Interfering; Transfection | 2012 |
Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Endocytosis; Galactose; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Hepatocytes; Humans; Lectins; Liver; Liver Neoplasms; Mice; Mice, Inbred ICR; Polyethyleneimine; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Transgenes | 2003 |
Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Galactose; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Male; Middle Aged; Palmitic Acid; Sensitivity and Specificity; Ultrasonography | 2003 |
Differential diagnosis of neonatal mild hypergalactosaemia detected by mass screening: clinical significance of portal vein imaging.
Topics: Acute Disease; alpha-Fetoproteins; Bile Acids and Salts; Chronic Disease; Galactose; Galactosemias; Hemangioendothelioma; Heterozygote; Humans; Infant, Newborn; Liver Neoplasms; Mass Screening; Metabolism, Inborn Errors; Portal System; Portal Vein; Severity of Illness Index; UDPglucose 4-Epimerase; Ultrasonography, Doppler, Color; UTP-Hexose-1-Phosphate Uridylyltransferase | 2004 |
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Topics: Absorption; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitin; Chitosan; DNA; Drug Carriers; Drug Delivery Systems; Drug Evaluation; Drug Stability; Galactose; Gene Targeting; Genetic Therapy; HeLa Cells; Humans; Liver Neoplasms; Nanotubes; Particle Size; Solubility; Transfection; Water | 2004 |
Improvement of C3A cell metabolism for usage in bioartificial liver support systems.
Topics: Albumins; Animals; Cell Line, Tumor; Cells, Cultured; Culture Media; Galactose; Gluconeogenesis; Hepatoblastoma; Hepatocytes; Humans; Liver Failure, Acute; Liver Neoplasms; Liver, Artificial; Swine; Time Factors; Urea | 2004 |
[Targeting delivery effect of galactose receptor-mediated c-myc antisense oligonucleotide on human hepatocellular carcinoma cell line Bel-7402].
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Galactose; Genes, myc; Humans; Liver Neoplasms; Lymphoma; Oligonucleotides, Antisense; Polyethyleneimine | 2004 |
Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Culture Media, Conditioned; Cytarabine; Drug Delivery Systems; Galactose; Humans; Liposomes; Liver Neoplasms; Macrophages, Peritoneal; Matrix Metalloproteinase 2; Oligopeptides; Particle Size; Phosphatidylethanolamines | 2006 |
[Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro].
Topics: Animals; Carcinoma, Hepatocellular; Cations; Cell Line, Tumor; Cholestenes; Drug Delivery Systems; Galactose; Humans; Liposomes; Liver; Liver Neoplasms; Male; Particle Size; Polidocanol; Polyethylene Glycols; Rats; Transfection | 2006 |
Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Galactose; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Logistic Models; Male; Microbubbles; Middle Aged; Neoplasm Metastasis; Palmitic Acid; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2006 |
In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chitosan; Chlorocebus aethiops; COS Cells; DNA; Drug Carriers; Galactose; HeLa Cells; Humans; Liver Neoplasms; Transfection | 2007 |
Intravenous galactose tolerance test with the use of an enzymatic method for the determination of galactose.
Topics: Alkaline Phosphatase; Galactose; Gallstones; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms | 1967 |
Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.
Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Line; Cytochrome c Group; Endocytosis; Exocytosis; Galactose; Glycoproteins; Humans; Kinetics; Liver Neoplasms; Orosomucoid; Receptors, Immunologic; Saponins | 1984 |
Isolation and culture of adult rat hepatocytes and preneoplastic nodules from diethylnitrosamine treated livers: glucose-6-phosphatase distribution, albumin synthesis and hepatic binding protein activity.
Topics: Albumins; Animals; Asialoglycoprotein Receptor; Carrier Proteins; Cells, Cultured; Diethylnitrosamine; Galactose; Glucose-6-Phosphatase; Liver; Liver Neoplasms; Nitrosamines; Precancerous Conditions; Rats | 1980 |
Glycoprotein of hepatitis B surface antigen (HBsAg) produced by PLC/PRF/5 hepatoma cells.
Topics: Acetylglucosamine; Carcinoma, Hepatocellular; Cell Line; Fucose; Galactose; Glycoproteins; Hepatitis B Surface Antigens; Humans; Liver Neoplasms; Mannose; Oligosaccharides; Sialic Acids; Viral Proteins | 1981 |
Hepatic recognition and catabolism of serum glycoproteins.
Topics: Acetylglucosamine; Animals; Blood Proteins; Carcinoma, Hepatocellular; Galactose; Glycoproteins; Homeostasis; Humans; Kinetics; Liver; Liver Neoplasms; Liver Regeneration; Mannose; Models, Biological; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Rabbits; Radioligand Assay; Receptors, Cell Surface; Sialic Acids | 1981 |
Versatile synthesis of bi- and tri-antennary galactose ligands: interaction with the Gal/GalNAc receptor of human hepatoma cells.
Topics: Animals; Carcinoma, Hepatocellular; Galactose; Humans; Ligands; Liver Neoplasms; Molecular Structure; Rats; Receptors, Cell Surface; Tumor Cells, Cultured | 1995 |
[Selective effectiveness of galactose-containing liposome IL-2 on liver lymphocytes].
Topics: Animals; Delayed-Action Preparations; Drug Carriers; Galactose; Infusions, Intra-Arterial; Interleukin-2; Liposomes; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Receptors, Cell Surface; Recombinant Proteins; T-Lymphocytes | 1994 |
Regulatory effects of galactose on galactose-1-phosphate uridyltransferase activity on human hepatoblastoma HepG2 cells.
Topics: Blotting, Northern; Culture Media; Galactose; Gene Expression Regulation, Neoplastic; Glucose; Hepatoblastoma; Humans; Hydrogen-Ion Concentration; Isoenzymes; Kinetics; Liver Neoplasms; RNA, Messenger; Tumor Cells, Cultured; UTP-Hexose-1-Phosphate Uridylyltransferase | 1994 |
Galactosylated histone-mediated gene transfer and expression.
Topics: Asialoglycoprotein Receptor; Asialoglycoproteins; Bacterial Proteins; Carcinoma, Hepatocellular; Chloramphenicol O-Acetyltransferase; DNA, Recombinant; Endocytosis; Galactose; Galactose Oxidase; Gene Expression; Gene Transfer Techniques; Glycosylation; Histones; Humans; Liver Neoplasms; Orosomucoid; Polylysine; Receptors, Cell Surface; Recombinant Fusion Proteins; Tumor Cells, Cultured | 1994 |
Metabolic effects of galactose on human HepG2 hepatoblastoma cells.
Topics: Analysis of Variance; Blood Proteins; Carbon Dioxide; Cell Death; Galactose; Glucosephosphate Dehydrogenase; Hepatoblastoma; Humans; Liver Neoplasms; Phosphoglucomutase; Tumor Cells, Cultured | 1994 |
Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin.
Topics: Adult; Aged; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Carrier Proteins; Female; Galactose; Hepatectomy; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prognosis; Radionuclide Imaging; Receptors, Cell Surface; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate | 1994 |
Fusion-mediated microinjection of lysozyme into HepG2 cells through hemagglutinin neuraminidase-depleted Sendai virus envelopes.
Topics: Asialoglycoprotein Receptor; Asialoglycoproteins; Biological Transport; Cell Line; Galactose; Hepatoblastoma; Humans; Kinetics; Liver Neoplasms; Membrane Fusion; Microinjections; Muramidase; Neuraminidase; Parainfluenza Virus 1, Human; Receptors, Cell Surface; Subcellular Fractions; Tumor Cells, Cultured; Viral Fusion Proteins | 1994 |
The influence of serum for spreading of tumor cells on synthetic glycolipid films.
Topics: Adenocarcinoma; Animals; Biocompatible Materials; Carcinoma, Hepatocellular; Cell Adhesion; Culture Media, Serum-Free; Electrophoresis, Polyacrylamide Gel; Galactose; Glucose; Glycolipids; HeLa Cells; Humans; Lactose; Liver Neoplasms; Maltose; Melanoma, Experimental; Mice; Phosphatidylcholines; Tumor Cells, Cultured | 1995 |
Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Galactose; Humans; Hypertension, Portal; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Purines | 1996 |
Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
Topics: 3T3 Cells; Animals; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Survival; Cholesterol; DNA; Drug Carriers; Galactose; Gene Transfer Techniques; Genetic Vectors; Humans; Liposomes; Liver Neoplasms; Mice; Plasmids; Receptors, Cell Surface; Transfection; Tumor Cells, Cultured | 1998 |
Glycosylation of immunoglobulin A influences its receptor binding.
Topics: Acetylgalactosamine; Acetylglucosamine; Carcinoma, Hepatocellular; Endocytosis; Galactose; Glucose; Glycosylation; Humans; Immunoglobulin A; Liver Neoplasms; N-Acetylneuraminic Acid; Neoplasm Proteins; Neuraminidase; Protein Binding; Protein Processing, Post-Translational; Receptors, Fc; Sialyltransferases; Sjogren's Syndrome; Tumor Cells, Cultured; U937 Cells | 1999 |
Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Data Interpretation, Statistical; Female; Follow-Up Studies; Galactose; Hepatectomy; Humans; Liver; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prospective Studies; Regression Analysis; Risk Factors; Survival Analysis; Time Factors | 2002 |
The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells.
Topics: Acrylamides; Active Transport, Cell Nucleus; Carcinoma, Hepatocellular; Cell Nucleus; Cytoplasm; Endocytosis; Galactose; Humans; Liver Neoplasms; Microinjections; Polymers; Time Factors; Tumor Cells, Cultured | 2001 |
Acceptor activity of subcellular membranes for two terminal sugars, galactose and sialic acid.
Topics: Animals; Carcinoma, Hepatocellular; Cell Membrane; Galactose; Galactosyltransferases; Golgi Apparatus; Hydrogen-Ion Concentration; Liver; Liver Neoplasms; Male; Membranes; Microsomes, Liver; Rats; Sialic Acids; Sialyltransferases | 1977 |
Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.
Topics: Acetylgalactosamine; Acetylglucosamine; Animals; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Colonic Neoplasms; Epitopes; Fluorescent Antibody Technique; Fucose; Galactose; Humans; Lectins; Liver; Liver Neoplasms; Mannose; Neoplasm Metastasis; Oligosaccharides; Papain; Precipitin Tests; Rabbits; Radioimmunoassay; Sialic Acids | 1975 |
Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells.
Topics: Animals; Carcinoma, Hepatocellular; Cells, Cultured; Chondroitin; Chromatography, Gel; Dermatan Sulfate; Fibroblasts; Galactose; Glycosaminoglycans; Glycosides; Heparitin Sulfate; Humans; Hyaluronic Acid; Hymecromone; Liver Neoplasms; Mice; Neuroblastoma; Neuroglia; Nitrophenols; Rats; Simian virus 40; Skin; Spectrometry, Fluorescence; Sulfur Radioisotopes; Sulfuric Acids; Tritium; Xylose | 1975 |
Preparation of carcinoembryonic antigen (CEA) containing significantly increased amounts of galactose and galactosamine.
Topics: Acetylgalactosamine; Amino Acids; Antigen-Antibody Reactions; Carbohydrates; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Chromatography, Agarose; Colonic Neoplasms; Galactosamine; Galactose; Hexosamines; Humans; Immunodiffusion; Liver Neoplasms; Neoplasm Metastasis; Sialic Acids | 1975 |
Gangliosides of hepatoma 27, normal and regenerating rat liver.
Topics: Animals; Carcinoma, Hepatocellular; Galactosamine; Galactose; Gangliosides; Glucose; Liver; Liver Neoplasms; Liver Regeneration; Microsomes; Microsomes, Liver; Mitochondria; Mitochondria, Liver; Neoplasms, Experimental; Rats; Sialic Acids; Sphingosine | 1976 |
High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase.
Topics: Aerobiosis; Animals; Biological Transport, Active; Carcinoma, Hepatocellular; Cells, Cultured; Galactose; Glucose; Glycolysis; Hexokinase; Kinetics; Liver Neoplasms; Mitochondria; Neoplasms, Experimental; Rats | 1977 |
[Radiolabeling of surface sialyl and galactosyl residues of Zajdela's ascitic hepatoma cells].
Topics: Animals; Carcinoma, Hepatocellular; Cells, Cultured; Galactose; Galactose Oxidase; Glycoproteins; Isotope Labeling; Liver Neoplasms; Neoplasms, Experimental; Neuraminidase; Rats; Sialic Acids; Tritium | 1978 |
[Intravenous galactose overload as a test of hepatic function].
Topics: Adolescent; Adult; Aged; Female; Galactose; Galactosemias; Humans; Injections, Intravenous; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Middle Aged | 1978 |
Measurement of intrahepatic shunted blood flow by ethanol-1-14C method as compared with D-galactose-1-14C method.
Topics: Ethanol; Galactose; Humans; Liver Circulation; Liver Cirrhosis; Liver Neoplasms | 1976 |
Heterogeneity of carcinoembryonic antigen. II. Monosaccharide composition of concanavalin A-reactive and -nonreactive CEA.
Topics: Acetylgalactosamine; Acetylglucosamine; Binding Sites; Carcinoembryonic Antigen; Chromatography, Affinity; Concanavalin A; Fucose; Galactose; Glucosamine; Humans; Liver Neoplasms; Mannose; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Binding; Rectal Neoplasms; Sialic Acids | 1975 |
Incorporation of the hexose analogue 2-deoxy-D-galactose into membrane glycoproteins in HepG2 cells.
Topics: Adenosine Triphosphate; Ascites; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Chromatography, Affinity; Chromatography, Gas; Chromatography, High Pressure Liquid; Fucose; Galactose; Humans; Kinetics; Liver Neoplasms; Membrane Glycoproteins; Polysaccharides; Radioisotope Dilution Technique; Tumor Cells, Cultured | 1992 |
Assessment of liver function using a novel galactose single point method.
Topics: Adult; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Galactose; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged | 1992 |
Effects of human HSS on hepatocyte and hepatoma cell proliferation and D-GAL induced acute liver failure.
Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Fetus; Galactose; Growth Substances; Humans; Liver; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Rats; Tumor Cells, Cultured | 1992 |
Arabinogalactan blockade of experimental metastases to liver by murine hepatoma.
Topics: Animals; Carbohydrate Sequence; Galactans; Galactose; Glycoproteins; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Transplantation; Organ Specificity | 1991 |
Liver regeneration and restoration of liver function after partial hepatectomy in patients with liver tumors.
Topics: Adult; Aged; Caffeine; Carcinoma, Hepatocellular; Female; Galactose; Hepatectomy; Humans; Liver; Liver Neoplasms; Liver Regeneration; Male; Middle Aged; Technetium; Time Factors; Tomography, Emission-Computed, Single-Photon | 1990 |
Adherence of a virulent strain of Listeria monocytogenes to the surface of a hepatocarcinoma cell line via lectin-substrate interaction.
Topics: Agglutination; Bacterial Adhesion; Carcinoma, Hepatocellular; Galactose; Lectins; Listeria monocytogenes; Liver Neoplasms; Temperature; Tumor Cells, Cultured; Virulence | 1990 |
Effect of galactose on interaction of N-(2-hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: preliminary application to an anticancer agent, daunomycin.
Topics: Acrylamides; Animals; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Daunorubicin; Drug Carriers; Galactose; Humans; Liver Neoplasms; Mice; Polymers; Rats; Time Factors; Tumor Cells, Cultured | 1989 |
Tumor cell-surface galactose correlates with the degree of colorectal liver metastasis.
Topics: Adenocarcinoma; Animals; Cell Membrane; Cell Separation; Colorectal Neoplasms; Female; Flow Cytometry; Galactose; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Tumor Cells, Cultured | 1989 |
Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.
Topics: Alkaline Phosphatase; Carcinoma, Hepatocellular; Galactose; Humans; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Serum Albumin | 1987 |
Galactose loading tests in patients with hepatocellular carcinoma for the assessment of chemotherapy.
Topics: Albumins; Alkaline Phosphatase; Carcinoma, Hepatocellular; Galactose; Humans; Liver; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Regression Analysis | 1987 |
The metabolism of cobalamin bound to transcobalamin II and to glycoproteins that bind Cbl in HepG2 cells (human hepatoma).
Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Line; Cobalt Radioisotopes; Cobamides; Galactose; Glycoproteins; Humans; Liver Neoplasms; Receptors, Immunologic; Time Factors; Transcobalamins; Vitamin B 12 | 1985 |
Evaluation of liver volume and liver function following hepatic resection in man.
Topics: Adult; Aged; Cholesterol; Cholinesterases; Female; Galactose; Hepatectomy; Humans; Kinetics; Liver; Liver Neoplasms; Liver Regeneration; Male; Middle Aged; Prothrombin Time; Serum Albumin | 1986 |
Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose.
Topics: Animals; Asialoglycoprotein Receptor; Asialoglycoproteins; Carrier Proteins; Galactans; Galactose; Lectins; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Sarcoma, Experimental | 1987 |
Analysis of a differential functional pattern between non-cirrhotic chronic liver disease and hepatic cirrhosis: a multivariate approach.
Topics: Ascites; Biopsy; Cholinesterases; Chronic Disease; Diagnosis, Differential; Esophageal and Gastric Varices; Galactose; gamma-Globulins; Hepatomegaly; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Radionuclide Imaging; Serum Albumin; Splenomegaly; Thymol | 1969 |
Measurement of intrahepatic shunted blood flow by means of D-galactose-1-C14 in experimental hepatic injuries.
Topics: Animals; Carbon Isotopes; Carbon Tetrachloride Poisoning; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Fatty Liver; Galactose; Hepatic Artery; Hepatic Veins; Liver Circulation; Liver Cirrhosis, Experimental; Liver Neoplasms; Male; Mesenteric Veins; Neoplasms, Experimental; Rats | 1970 |
Binding of radioactively labeled concanavalin A and Ricinus communis agglutinin to rat liver- and rat ascites hepatoma-nuclei.
Topics: Animals; Carbohydrates; Carcinoma, Hepatocellular; Cell Nucleus; Cells, Cultured; Chromatography; Chromatography, Gel; Concanavalin A; Galactose; Lectins; Liver; Liver Neoplasms; Mannose; Neoplasms, Experimental; Rats; Receptors, Drug; Tritium | 1972 |
Carbohydrate composition of rat hepatocyte nuclear membrane as compared to normal, Morris hepatoma 7800, and phenobarbital-induced microsomal membranes.
Topics: Animals; Carbohydrates; Carcinoma, Hepatocellular; Cell Nucleus; Chromatography, Gas; Galactosamine; Galactose; Glucosamine; Glucose; Liver; Liver Neoplasms; Mannose; Membranes; Microsomes, Liver; Neoplasms, Experimental; Neuraminic Acids; Phenobarbital; Rats | 1973 |
Nucleotide contents of ascites hepatoma cells and their changes induced by D-galactosamine.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Chromatography, Paper; Cytosine Nucleotides; Galactosamine; Galactose; Glucose; Glucuronates; Guanine Nucleotides; Hexosamines; Liver; Liver Glycogen; Liver Neoplasms; Neoplasms, Experimental; Rats; Ribonucleotides; Uracil Nucleotides; Uridine | 1974 |
The isolation and characterization of glycopeptides from plasma membranes of an ascites hepatoma, AH 66.
Topics: Amino Acids; Animals; Carcinoma, Hepatocellular; Cell Membrane; Centrifugation, Density Gradient; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis; Female; Fucose; Galactosamine; Galactose; Glucosamine; Glucose; Glycopeptides; Heparitin Sulfate; Inositol; Liver Neoplasms; Mannose; Microscopy, Phase-Contrast; Molecular Weight; Protein Binding; Rats; Sialic Acids; Sulfur Radioisotopes; Tritium; Uronic Acids | 1974 |
[Modern diagnosis of liver function in the chemical laboratory. I. Disturbances of liver cell integrity and metabolic efficiency].
Topics: Albumins; Ammonia; Blood Coagulation Factors; Cholestasis; Cholinesterases; Chronic Disease; Diagnosis, Differential; Fatty Liver; Galactose; Hepatitis; Hepatitis A; Humans; Iron Isotopes; Jaundice; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms | 1972 |
Physiologic measurement of intrahepatic shunted blood flow by means of D-galactose-1-C14.
Topics: Biopsy; Brachial Artery; Carbon Isotopes; Coloring Agents; Galactose; Hepatic Veins; Hepatitis A; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Methods; Regional Blood Flow; Saphenous Vein; Vena Cava, Superior; Venous Pressure | 1971 |
Glycoproteins in human bile.
Topics: Amino Acids; Bile; Cholelithiasis; Chromatography, Ion Exchange; Electrophoresis; Fucose; Galactosamine; Galactose; Glucosamine; Glycoproteins; Humans; Liver Neoplasms; Mannose; Neuraminic Acids; Pancreatitis; Pronase | 1971 |
An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
Topics: Adult; Cholestasis; Female; Galactose; Hepatitis A; Humans; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Sulfobromophthalein | 1966 |
Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.
Topics: Adult; Amino Acids; Bile Duct Neoplasms; Biogenic Amines; Blood Proteins; Body Mass Index; Carcinoma; Carnitine; Case-Control Studies; Diabetes Mellitus; Europe; Gene Expression; Hexoses; Humans; Linear Models; Liver Neoplasms; Longitudinal Studies; Male; Metabolome; Middle Aged; Nutrition Assessment; Obesity; Phosphatidylcholines; Risk Factors; Sphingomyelins | 2017 |
Genotoxic and antigenotoxic effects of catechin and tannins from the bark of Hamamelis virginiana L. in metabolically competent, human hepatoma cells (Hep G2) using single cell gel electrophoresis.
Topics: Anthocyanins; Antineoplastic Agents, Phytogenic; Benzo(a)pyrene; Carcinoma, Hepatocellular; Catechin; Cytochrome P-450 CYP1A1; DNA Damage; Electrophoresis, Agar Gel; Gallic Acid; Hamamelis; Hexoses; Humans; Liver Neoplasms; Mutagens; Plant Bark; Proanthocyanidins; Tumor Cells, Cultured | 2003 |
[ACTION OF METABOLIC INHIBITORS ON ENERGY METABOLISM AND ON PROTEIN SYNTHESIS OF TUMOR AND EMBRYONAL CELLS].
Topics: Adenosine Triphosphate; Amino Acids; Antimetabolites; Carcinoma, Hepatocellular; Cell Biology; Chick Embryo; Dinitrophenols; Embryo, Mammalian; Embryo, Nonmammalian; Energy Metabolism; Glycine; Hexoses; Leucine; Liver Neoplasms; Manometry; Metabolism; Neoplasms; Neoplasms, Experimental; Pharmacology; Protein Biosynthesis; Proteins; Rats; Research | 1963 |
SERUM ENZYMES IN DISEASE. XV. GLYCOLYTIC AND OXIDATIVE ENZYMES AND TRANSAMINASES IN PATIENTS WITH CARCINOMA OF THE KIDNEY, PROSTATE AND URINARY BLADDER.
Topics: Acid Phosphatase; Adenocarcinoma; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bone Neoplasms; Clinical Enzyme Tests; Dysgerminoma; Female; Fructose-Bisphosphate Aldolase; Glutathione; Hexoses; Humans; Isocitrate Dehydrogenase; Isomerases; Kidney Neoplasms; L-Lactate Dehydrogenase; Liver Function Tests; Liver Neoplasms; Malate Dehydrogenase; Male; Neoplasm Metastasis; Ovarian Neoplasms; Oxidoreductases; Prostatic Neoplasms; Transaminases; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1964 |
[SERUM GLYCOPROTEINS IN CHRONIC LIVER DISEASES].
Topics: Blood Proteins; Glycoproteins; Hexoses; Humans; Liver Diseases; Liver Neoplasms; Neuraminic Acids | 1964 |
Molecular characterization of tumor associated antigen in mice exposed to a hepatocarcinogen.
Topics: Acetylcholinesterase; Animals; Antigens, Tumor-Associated, Carbohydrate; Carbohydrates; Carcinogens; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; gamma-Glutamyltransferase; Glutathione; Glutathione Transferase; Glycosylation; Hepatocytes; Hexoses; Liver; Liver Neoplasms; Membrane Glycoproteins; Mice; N-Acetylneuraminic Acid; Nitrosamines | 2005 |
alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.
Topics: Ammonium Chloride; Azides; Carcinoma, Hepatocellular; Cell Line; Chloroquine; Dose-Response Relationship, Drug; Fucose; Glycated Serum Albumin; Glycation End Products, Advanced; Hexoses; Humans; Iodine Radioisotopes; Kinetics; Liver Neoplasms; Receptors, Cell Surface; Serum Albumin; Sodium Azide; Sodium Fluoride; Stereoisomerism; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1994 |
Conditional, tissue-specific expression of Q205L G alpha i2 in vivo mimics insulin action.
Topics: Adipocytes; Animals; Biological Transport; Carcinoma, Hepatocellular; Cell Membrane; Cells, Cultured; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Glycogen Synthase; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Proteins; Hexoses; Insulin; Liver; Liver Neoplasms; Mice; Mice, Transgenic; Monosaccharide Transport Proteins; Muscle Proteins; Mutation; Organ Specificity; Phosphoenolpyruvate Carboxykinase (GTP); Promoter Regions, Genetic; Proto-Oncogene Proteins; Rats; Tumor Cells, Cultured | 1997 |
Multisite control of the Crabtree effect in ascites hepatoma cells.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Ascites; Calcium; Carcinoma, Hepatocellular; Cytosol; Female; Fructose; Fructosediphosphates; Fructosephosphates; Glucose; Glucose-6-Phosphate; Hexoses; Hydrogen-Ion Concentration; Kinetics; Liver Neoplasms; Magnesium; Mitochondria; Oxygen; Oxygen Consumption; Phosphorylation; Rats; Rats, Wistar; Saccharomyces cerevisiae; Tumor Cells, Cultured | 2001 |
The isolation and characterization of glycopeptides and mucopolysaccharides from plasma membranes of an ascites hepatoma, AH 130.
Topics: Animals; Aspartic Acid; Carcinoma, Hepatocellular; Cell Membrane; Female; Glycopeptides; Glycosaminoglycans; Heparitin Sulfate; Hexosamines; Hexoses; Liver Neoplasms; Rats; Serine; Sialic Acids; Sulfuric Acid Esters; Threonine | 1975 |
Partial characterization of rat hepatoma cell-surface glycopeptides possessing concanavalin A receptor activity.
Topics: Amino Acids; Animals; Carcinoma, Hepatocellular; Cell Membrane; Glycopeptides; Hexosamines; Hexoses; Liver Neoplasms; Neoplasms, Experimental; Rats; Receptors, Concanavalin A; Receptors, Drug; Sialic Acids | 1976 |
The isolation and characterization of glycopeptides and mucopolysaccharides from plasma membranes of an ascites hepatoma, AH 130 FN.
Topics: Amino Acids; Animals; Carcinoma, Hepatocellular; Cell Membrane; Cells, Cultured; Female; Glycopeptides; Glycosaminoglycans; Hexoses; Liver Neoplasms; Rats; Sialic Acids | 1976 |
Specific alterations of fucoprotein biosynthesis in the plasma membrane of Morris hepatoma 7777.
Topics: Carcinoma, Hepatocellular; Cell Membrane; Fucose; Glycoproteins; Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose; Hexosamines; Hexoses; Liver; Liver Neoplasms; Neoplasms, Experimental | 1978 |
Glycopeptide and glycosaminoglycans in the process of hepatic cancer induced by 3'-methyl-DAB.
Topics: Animals; Glycopeptides; Glycosaminoglycans; Hexosamines; Hexoses; Liver Neoplasms; Male; Methyldimethylaminoazobenzene; Neoplasms, Experimental; Rats; Sialic Acids; Uronic Acids | 1978 |
[Role of a carbohydrate component in the formation of immunochemical determinants of carcinoembryonic antigen].
Topics: Adenocarcinoma; Amino Acids; Carcinoembryonic Antigen; Chemical Phenomena; Chemistry; Circular Dichroism; Colonic Neoplasms; Cross Reactions; Epitopes; Hexoses; Humans; Immunodiffusion; Liver Neoplasms; Sialoglycoproteins | 1985 |
Incorporation of 2-deoxyglucose into glycogen by intact Novikoff ascites hepatoma.
Topics: Carbon Isotopes; Carcinoma, Hepatocellular; Dinitrophenols; Glycogen; Hexoses; In Vitro Techniques; Liver Neoplasms; Neoplasms, Experimental | 1967 |
Studies on respiration and glycolysis in transplanted hepatic tumors of the rat.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Hepatocellular; Female; Glycolysis; Hexoses; Lactates; Liver Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Oxidative Phosphorylation; Oxygen Consumption; Phosphotransferases; Rats | 1968 |
Kinetic, electrophoretic, and chromatographic studies on glucose-ATP phosphotransferases in rat hepatomas.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Hepatocellular; Cellulose; Chromatography; Electrophoresis; Gels; Glucokinase; Glucose; Hexokinase; Hexoses; Isoenzymes; Kidney; Kidney Neoplasms; Kinetics; Liver; Liver Neoplasms; Male; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Experimental; Phosphotransferases; Rats; Starch | 1969 |
[Pathological biochemistry of tumor bearing animals. 9. Seum glycoproteins].
Topics: Animals; Ascites; Blood Protein Electrophoresis; Blood Proteins; Carcinoma, Hepatocellular; Fucose; Glycoproteins; Hexosamines; Hexoses; Liver Neoplasms; Neoplasms, Experimental; Neuraminic Acids; Rats | 1970 |
Carbohydrate composition of the plasma membranes of rat ascites hepatoma.
Topics: Animals; Carbohydrates; Carcinoma, Hepatocellular; Cell Membrane; Glycolipids; Glycoproteins; Hexosamines; Hexoses; Liver Neoplasms; Microscopy, Electron; Neoplasms, Experimental; Neuraminic Acids; Rats | 1970 |
[Changes in the carbohydrate composition of fibrinogen in cases of acquired dysfibrinogenemia].
Topics: Blood Coagulation Disorders; Blood Protein Disorders; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Fibrinogen; Hexosamines; Hexoses; Humans; Jaundice; Liver Cirrhosis; Liver Neoplasms; Neuraminic Acids | 1970 |
L-glutamine:D-fructose 6-phosphate amidotransferase in tumors and the liver of tumor-bearing animals.
Topics: Animals; Ascitic Fluid; Brain; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Chemical Precipitation; Chromatography, Gel; Colon; Dialysis; Dithiothreitol; Fructosephosphates; Glucosamine; Glucosephosphates; Glutamine; Glycosaminoglycans; Hexoses; Intestines; Kidney; Kinetics; Liver; Liver Neoplasms; Lung; Male; Mice; Muscles; Myocardium; Neoplasm Transplantation; Neoplasms, Experimental; Nucleoside Diphosphate Sugars; Rats; Sarcoma, Yoshida; Spleen; Stomach; Transaminases; Uracil Nucleotides | 1971 |
Inhibition of the transport of several hexoses in mammalian cells by cytochalasin B.
Topics: Aminoisobutyric Acids; Animals; Biological Transport; Calcium; Carbon Isotopes; Carcinoma, Hepatocellular; Cells, Cultured; Chick Embryo; Glucosamine; Glucose; Heart; HeLa Cells; Hexokinase; Hexoses; Humans; Liver Neoplasms; Mice; Mycotoxins; Myocardium; Neoplasms, Experimental; Rats; Thymidine; Tritium; Uridine | 1972 |
Cytochalasin B: inhibition of glucose and glucosamine transport.
Topics: Animals; Biological Transport; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line; Depression, Chemical; Glucosamine; Glucose; Hexoses; Kinetics; Liver Neoplasms; Macromolecular Substances; Mycotoxins; Neoplasms, Experimental; Oxidative Phosphorylation; Rats | 1972 |
Isolation and analysis of glycopeptides from microsomes of an ascites hepatoma, AH 66.
Topics: Amino Acids; Animals; Carbohydrates; Carcinoma, Hepatocellular; Chromatography; Electrophoresis, Paper; Female; Glycopeptides; Hexoses; Liver Neoplasms; Microsomes, Liver; Pronase; Rats | 1972 |
Serum glycoprotein levels in the rat bearing ascites hepatoma 109A.
Topics: Animals; Ascites; Blood Proteins; Carcinoma, Hepatocellular; Circadian Rhythm; Electrophoresis; Fasting; Glycoproteins; Hexosamines; Hexoses; Liver Neoplasms; Male; Neoplasm Transplantation; Neoplasms, Experimental; Neuraminic Acids; Rats | 1972 |
Isolation and chemical characterization of mucopolysaccharides from rat tumors.
Topics: Animals; Carcinoma, Hepatocellular; Chondroitin; Chromatography, Ion Exchange; Electrophoresis; Glucosamine; Glycosaminoglycans; Heparin; Hexosamines; Hexoses; Hyaluronic Acid; Liver Neoplasms; Methylcholanthrene; Neoplasm Transplantation; Neoplasms, Experimental; Proteins; Rats; Sarcoma, Experimental; Spectrophotometry, Infrared; Sulfates; Transplantation, Homologous; Uronic Acids | 1974 |
Concanavalin A and wheat germ agglutinin receptor activity of sialoglycopeptides isolated from the surface of Novikoff hepatoma cells.
Topics: Amino Acids; Animals; Binding Sites; Carcinoma, Hepatocellular; Chromatography, Gel; Chromatography, Ion Exchange; Concanavalin A; Female; Galactosamine; Glucosamine; Glycopeptides; Hexoses; Kinetics; Lectins; Liver Neoplasms; Neoplasms, Experimental; Papain; Plant Lectins; Pronase; Protein Binding; Rats; Receptors, Drug; Sialic Acids; Triticum | 1974 |
Factors affecting anaerobic glycolysis in mouse and rat liver and in Morris rat hepatomas.
Topics: Animals; Carbon Dioxide; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Glycolysis; Hexoses; Insulin; Lactates; Liver; Liver Glycogen; Liver Neoplasms; Manometry; Melanoma; Mice; NAD; NADP; Neoplasms, Experimental; Pyruvates; Rats | 1968 |
D-glucose suppression of tyrosine aminotransferase in rat-hepatoma cells grown in culture.
Topics: Animals; Carcinoma, Hepatocellular; Cells, Cultured; Culture Media; Cycloheximide; Dactinomycin; Enzyme Induction; Glucosamine; Glucose; Hexoses; In Vitro Techniques; Lactose; Liver Neoplasms; Mannitol; Rats; Stereoisomerism; Tyrosine; Tyrosine Transaminase | 1971 |
Glucocorticoids: competitive inhibition of glucose transport.
Topics: Animals; Biological Transport; Carbon Dioxide; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line; Chromatography, Paper; Depression, Chemical; Glucose; Hexosephosphates; Hexoses; Kinetics; Lactates; Liver Neoplasms; Neoplasms, Experimental; Prednisolone; Rats; Tyrosine Transaminase | 1972 |